Why the study?
Does pindolol alter heart rate and blood pressure differently than propranolol and placebo in hypertensive African patients?
Does pindolol alter heart rate and blood pressure differently than propranolol and placebo in hypertensive African patients?
Pindolol and propranolol exhibit distinct hemodynamic profiles in hypertensive African patients, with maximal beta-blocking effects correlating with peak plasma concentrations at 2 hours.
Supports tailored beta-blocker selection to preserve resting heart rate; extends distinct hemodynamic profiles to hypertensive African patients.
The beta-adrenoreceptor-blocking effects of pindolol were compared with those of propranolol and a placebo in a double-blind cross-over trial involving nine hypertensive African patients. 2. Heart rate, systolic blood pressure and diastolic blood pressure were measured at rest and immediately after exercise before and at intervals up to 6 h after oral administration of the drugs. In addition, plasma pindolol and propranolol concentrations were determined at the same intervals. 3. Pindolol diminished systolic blood pressure at rest and after exercise and antagonized exercise-induced tachycardia, but had no effect on resting heart rate. Propranolol diminished systolic blood pressure predominantly after exercise and reduced both resting and exercise heart rate. Both drugs had no effect on diastolic pressure. 4. The mean plasma concentration reached a peak at 2 h for each drug and this coincide with the interval at which maximal beta-adrenoreceptor-blocking effect was observed.
No takes yet. Share an insight, caveat, or question.
Salako et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: